98%
921
2 minutes
20
MXene-based smart contact lenses demonstrate a cutting-edge advancement in wearable ophthalmic technology, combining real-time biosensing, therapeutic capabilities, and user comfort in a single platform. These devices take the advantage of the exceptional electrical conductivity, mechanical flexibility, and biocompatibility of two-dimensional MXenes to enable noninvasive, tear-based monitoring of key physiological markers such as intraocular pressure and glucose levels. Recent developments focus on the integration of transparent MXene films into the conventional lens materials, allowing multifunctional performance including photothermal therapy, antimicrobial and anti-inflammation protection, and dehydration resistance. These innovations offer promising strategies for ocular disease management and eye protection. In addition to their multifunctionality, improvements in MXene synthesis and device engineering have enhanced the stability, transparency, and wearability of these lenses. Despite these advances, challenges remain in long-term biostability, scalable production, and integration with wireless communication systems. This review summarizes the current progress, key challenges, and future directions of MXene-based smart contact lenses, highlighting their transformative potential in next-generation digital healthcare and ophthalmic care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325838 | PMC |
http://dx.doi.org/10.1007/s40820-025-01863-5 | DOI Listing |
J Refract Surg
September 2025
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Purpose: To report a case of acute and transient accommodative insufficiency after laser in situ keratomileusis (LASIK) due to coronavirus disease 2019 (COVID-19).
Methods: Case report and literature review.
Results: A 36-year-old man complained of acute blurred near vision 7 days after uneventful bilateral hyperopic LASIK, concurrent with the onset of COVID-19 infection.
Clin Ophthalmol
August 2025
Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, ON, Canada.
Purpose: To evaluate the effectiveness of lifitegrast ophthalmic solution 5% in alleviating end-of-day dryness and discomfort in symptomatic contact lens (CL) wearers.
Patients And Methods: This was an open-label study in symptomatic CL wearers with ratings of ≥40 for end-of-day dryness on a visual analog scale (VAS; 0-100 scale; 100 worst). Participants wore their habitual CLs and instilled lifitegrast twice daily for 12 weeks with lenses removed.
Clin Ophthalmol
August 2025
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada.
Purpose: This study aims to evaluate rotational stability and patient-reported outcomes associated with Tecnis Eyhance toric II "monofocal plus" intraocular lens (IOL), particularly in light of a modified haptic design.
Methods: A prospective, interventional study was conducted with patients undergoing routine cataract surgery and Tecnis Eyhance toric II IOL implantation. The inclusion criteria were topographic corneal astigmatism of 0.
BMC Ophthalmol
September 2025
Optometry Center, Shaanxi Key Laboratory of Ophthalmology, Xi'an No.1 Hospital (the First Affiliated Hospital of Northwest University), Shaanxi Institute of Ophthalmology, No.30, Fenxiang Alley, South Street, Xi'an, Shaanxi Province, 710002, China.
Purpose: To determine the baseline ocular biometrics in children with axial length reduction after orthokeratology for better myopia control.
Methods: Changes in ocular parameters in 164 subjects who completed one year of Ortho-K treatment were retrospectively reviewed. The subjects were divided into AL reduction (n = 105, ≤ 0 mm/year axial growth) and AL elongation (n = 59, ≥ 0.
J Optom
June 2025
School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. Electronic address:
Introduction: This review aims to analyse the application of the measure methods and measure contents of the outcomes reported in studies on slowing myopia, and the associations between outcomes and study characteristics.
Methods: Publications were identified by a search of seven electronic databases including China National Knowledge Infrastructure, China Biology Medicine, Wanfang database, CQVIP database, PubMed, Cochrane Library and Excerpta Medica Database, for relevant terms like myopia and randomized controlled trial from construction to Sept. 15th, 2023.